IGM Biosciences to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

IGM Biosciences (Nasdaq: IGMS), a clinical-stage biotechnology company, will participate in a fireside chat at the Jefferies London Healthcare Conference on November 17, 2021, at 1:40 p.m. GMT (8:40 a.m. EST). A live webcast of the event will be accessible on the Company’s website in the Investors section, with a replay available for 90 days thereafter. IGM focuses on developing engineered IgM antibodies to tackle challenges in therapeutic use, leveraging its proprietary technology platform since 2010.

MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 17, 2021 at 1:40 p.m. GMT/ 8:40 a.m. EST.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

When is IGM Biosciences participating in the Jefferies London Healthcare Conference?

IGM Biosciences will participate on November 17, 2021, at 1:40 p.m. GMT.

How can I access the IGM Biosciences fireside chat?

You can access the fireside chat via a live webcast on the Company's website under the Investors section.

Where is IGM Biosciences headquartered?

IGM Biosciences is headquartered in Mountain View, California.

What is the focus of IGM Biosciences?

IGM Biosciences is focused on creating and developing engineered IgM antibodies.

How long will the webcast of the IGM Biosciences event be available?

The webcast will be archived for 90 days following the presentation.